Research Papers

25 of 530 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Subclonal evolution and expansion of spatially distinct THY1-positive cells is associated with recurrence in glioblasto…
Al-Holou WN; Wang H; Ravikumar V; Shankar S; Oneka M; Fehmi Z; Verhaak RG; Kim H; Pratt D; Camelo-Piragua S; Speers C; Wahl DR; Hollon T; Sagher O; Heth JA; Muraszko KM; Lawrence TS; de Carvalho AC; Mikkelsen T; Rao A; Rehemtulla A.
Neoplasia (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Targeted and explorative profiling of kallikrein proteases and global proteome biology of pancreatic ductal adenocarcin…
Werner J; Bernhard P; Cosenza-Contreras M; Pinter N; Fahrner M; Pallavi P; Eberhard J; Bronsert P; Rückert F; Schilling O.
Neoplasia (Unknown)
Published: 2023
5/6 Transparent
Data Code Funding Declared
Locoregional CAR T cells for children with CNS tumors: Clinical procedure and catheter safety.
Vitanza NA; Ronsley R; Choe M; Henson C; Breedt M; Barrios-Anderson A; Wein A; Brown C; Beebe A; Kong A; Kirkey D; Lee BM; Leary SES; Crotty EE; Hoeppner C; Holtzclaw S; Wilson AL; Gustafson JA; Foster JB; Iliff JJ; Goldstein HE; Browd SR; Lee A; Ojemann JG; Pinto N; Gust J; Gardner RA; Jensen MC; Hauptman JS; Park JR.
Neoplasia (Unknown)
Published: 2023
2/6 Transparent
Post-irradiation intratumoral heterogeneity modulates response to immune checkpoint inhibition therapy in a murine mela…
Wang J; Sud S; Qu Y; Li L; Zhang J; Marron D; Knape NM; Kim IJ; Wagner KT; Zhang T; Zhao Y; Guo G; Wang AZ.
Neoplasia (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Pediatric low-grade glioma: Targeted therapeutics and clinical trials in the molecular era.
Manoharan N; Liu KX; Mueller S; Haas-Kogan DA; Bandopadhayay P.
Neoplasia (Unknown)
Published: 2022
2/6 Transparent
A systematic review of microbiome-derived biomarkers for early colorectal cancer detection.
Zwezerijnen-Jiwa FH; Sivov H; Paizs P; Zafeiropoulou K; Kinross J.
Neoplasia (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Synergizing radiotherapy and immunotherapy: Current challenges and strategies for optimization.
Rajeev-Kumar G; Pitroda SP.
Neoplasia (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
FOXM1 increases hTERT protein stability and indicates poor prognosis in gastric cancer.
Tang Q; Liu C; Zhang S; He L; Liu Y; Wang J; Zhao X; Li X.
Neoplasia (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Primary central nervous system germ cell tumors in children and young adults: A review of controversies in diagnostic a…
Yeo KK; Nagabushan S; Dhall G; Abdelbaki MS.
Neoplasia (Unknown)
Published: 2022
2/6 Transparent
Current studies and future directions for medulloblastoma: A review from the pacific pediatric neuro-oncology consortiu…
Cooney T; Lindsay H; Leary S; Wechsler-Reya R.
Neoplasia (Unknown)
Published: 2022
2/6 Transparent
FAPα and αSMA mark different subsets of fibroblasts in normal kidney and conventional renal cell carcinoma.
Peterfi L; Yusenko MV; Kovacs G; Beothe T.
Neoplasia (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Cerebrospinal Fluid biomarkers in pediatric brain tumors: A systematic review.
Lehner KR; Jiang K; Rincon-Torroella J; Perera R; Bettegowda C.
Neoplasia (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Targeting Na-H exchanger 1 overcomes nuclear factor kappa B-mediated tumor resistance to radiotherapy.
Son A; Kang S; Choi S; Shin SW; Kim Y; Kim W; Choi C.
Neoplasia (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Proteomic profiling of canine fibrosarcoma and adjacent peritumoral tissue.
Beebe E; Pöschel A; Kunz L; Wolski W; Motamed Z; Meier D; Guscetti F; Nolff MC; Markkanen E.
Neoplasia (Unknown)
Published: 2022
4/6 Transparent
Data Funding Declared
A G-quadruplex stabilizer, CX-5461 combined with two immune checkpoint inhibitors enhances in vivo therapeutic efficacy…
Chung SY; Chang YC; Hsu DS; Hung YC; Lu ML; Hung YP; Chiang NJ; Yeh CN; Hsiao M; Soong J; Su Y; Chen MH.
Neoplasia (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Tumor-associated tissue eosinophilia promotes angiogenesis and metastasis in head and neck squamous cell carcinoma.
Lee TL; Chen TH; Kuo YJ; Lan HY; Yang MH; Chu PY.
Neoplasia (Unknown)
Published: 2022
4/6 Transparent
Data Funding Declared
Interdisciplinary care of children with diffuse midline glioma.
Coleman C; Chen K; Lu A; Seashore E; Stoller S; Davis T; Braunstein S; Gupta N; Mueller S.
Neoplasia (Unknown)
Published: 2022
2/6 Transparent
LGR6-dependent conditional inactivation of E-cadherin and p53 leads to invasive skin and mammary carcinomas in mice.
Ter Steege EJ; Sijnesael T; Enserink L; Klarenbeek S; Haakma WE; Bakker ERM; Derksen PWB.
Neoplasia (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
The kinetics of blast clearance are associated with copy number alterations in childhood B-cell acute lymphoblastic leu…
Urbańska Z; Lejman M; Taha J; Madzio J; Ostrowska K; Miarka-Walczyk K; Wypyszczak K; Styka B; Jakubowska J; Sędek Ł; Szczepański T; Stańczak M; Fendler W; Młynarski W; Pastorczak A.
Neoplasia (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Colorectal cancer, Vitamin D and microbiota: A double-blind Phase II randomized trial (ColoViD) in colorectal cancer pa…
Bellerba F; Serrano D; Johansson H; Pozzi C; Segata N; NabiNejad A; Piperni E; Gnagnarella P; Macis D; Aristarco V; Accornero CA; Manghi P; Guerrieri-Gonzaga A; Biffi R; Bottiglieri L; Trovato C; Zampino MG; Corso F; Bellocco R; Raimondi S; Rescigno M; Gandini S.
Neoplasia (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Targeting GRP78 suppresses oncogenic KRAS protein expression and reduces viability of cancer cells bearing various KRAS…
Ha DP; Huang B; Wang H; Rangel DF; Van Krieken R; Liu Z; Samanta S; Neamati N; Lee AS.
Neoplasia (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
PAD4-dependent citrullination of nuclear translocation of GSK3β promotes colorectal cancer progression via the degradat…
Luo X; Chang S; Xiao S; Peng Y; Gao Y; Hu F; Liang J; Xu Y; Du K; Chen Y; Qin J; Meltzer SJ; Deng S; Feng X; Fan X; Hou G; Jin Z; Zhang X.
Neoplasia (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Targeting interleukin 4 receptor alpha on tumor-associated macrophages reduces the pro-tumor macrophage phenotype.
de Groot AE; Myers KV; Krueger TEG; Brennen WN; Amend SR; Pienta KJ.
Neoplasia (Unknown)
Published: 2022
2/6 Transparent
Funding Declared
Microbiota-driven mechanisms at different stages of cancer development.
Ivleva EA; Grivennikov SI.
Neoplasia (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Metabolic reprogramming by adenosine antagonism and implications in non-small cell lung cancer therapy.
Guan S; Suman S; Amann JM; Wu R; Carbone DP; Wang J; Dikov MM.
Neoplasia (Unknown)
Published: 2022
3/6 Transparent
Funding Declared